{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-24T19:18:18.363043+00:00","published_at":"2026-10-24T04:46:03.478019+00:00","section":"evidence","data":{"state":"PUBLISHED","evidence":[{"evidence_id":"alpha:projection-evidence:f103d8d9f0172e65195a9e08016a429299a77ae35ed262aad96bdb36a602fbc8","aliases":[],"source_type":"canonical_identity","source_family":"open_web","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bicara-therapeutics-inc","title":"Alpha canonical company public projection","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-10-24T04:46:03.478019+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:legal_name:1","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:entity_status:3","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:published_fact:4","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:published_fact:5","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:published_fact:6","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:security_listing:20","stance":"supports"}],"claim_ids":["alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:legal_name:1","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:entity_status:3","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:published_fact:4","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:published_fact:5","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:published_fact:6","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:security_listing:20"]},{"evidence_id":"alpha:projection-evidence:document:927e406b211f29d8d30e9f50a6e7c5996a5721bafe2dfd78b98fe89a08504954","aliases":[],"source_type":"sec_proxy","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","title":"DEF 14A bcax-20260427.htm","identifier":null,"locator":null,"source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:05:39.007738+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:7","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:8","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:9","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:10","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:11","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:12","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:13","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:14","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:15","stance":"supports"}],"claim_ids":["alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:7","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:8","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:9","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:10","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:11","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:12","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:13","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:14","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:15"]},{"evidence_id":"alpha:projection-evidence:ba527dee1414de817618527ef612d097a7faa1a57dce68db723c2f2627666edb","aliases":[],"source_type":"sec_proxy","source_family":"sec","publisher":"governance_people_committees","url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","title":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","identifier":null,"locator":null,"source_date":null,"retrieved_at":null,"content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_record:16","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:17","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:18","stance":"supports"},{"claim_id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:19","stance":"supports"}],"claim_ids":["alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_record:16","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:17","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:18","alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:19"]}]},"claims":[{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:legal_name:1","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Bicara Therapeutics Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"Bicara Therapeutics Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:f103d8d9f0172e65195a9e08016a429299a77ae35ed262aad96bdb36a602fbc8","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bicara-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-24T04:46:03.478019+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:entity_status:3","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:f103d8d9f0172e65195a9e08016a429299a77ae35ed262aad96bdb36a602fbc8","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bicara-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-24T04:46:03.478019+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:published_fact:4","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:f103d8d9f0172e65195a9e08016a429299a77ae35ed262aad96bdb36a602fbc8","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bicara-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-24T04:46:03.478019+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:published_fact:5","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:sector","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Healthcare","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"Healthcare","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:f103d8d9f0172e65195a9e08016a429299a77ae35ed262aad96bdb36a602fbc8","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bicara-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-24T04:46:03.478019+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:published_fact:6","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:industry","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Biotechnology","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"Biotechnology","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:f103d8d9f0172e65195a9e08016a429299a77ae35ed262aad96bdb36a602fbc8","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bicara-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-24T04:46:03.478019+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:7","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:carolyn-ng-bcax","object_label":"Carolyn Ng","object_source_name_forms":[],"value":"Carolyn Ng: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:carolyn-ng-bcax","name":"Carolyn Ng"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:document:927e406b211f29d8d30e9f50a6e7c5996a5721bafe2dfd78b98fe89a08504954","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A bcax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:05:39.007738+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:8","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christopher-bowden-bcax","object_label":"Christopher Bowden","object_source_name_forms":[],"value":"Christopher Bowden: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christopher-bowden-bcax","name":"Christopher Bowden"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:document:927e406b211f29d8d30e9f50a6e7c5996a5721bafe2dfd78b98fe89a08504954","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A bcax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:05:39.007738+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:9","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:claire-mazumdar-bcax","object_label":"Claire Mazumdar","object_source_name_forms":[],"value":"Claire Mazumdar: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:claire-mazumdar-bcax","name":"Claire Mazumdar"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:document:927e406b211f29d8d30e9f50a6e7c5996a5721bafe2dfd78b98fe89a08504954","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A bcax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:05:39.007738+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:10","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jake-simson-bcax","object_label":"Jake Simson","object_source_name_forms":[],"value":"Jake Simson: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jake-simson-bcax","name":"Jake Simson"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:document:927e406b211f29d8d30e9f50a6e7c5996a5721bafe2dfd78b98fe89a08504954","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A bcax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:05:39.007738+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:11","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kate-haviland-bcax","object_label":"Kate Haviland","object_source_name_forms":[],"value":"Kate Haviland: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kate-haviland-bcax","name":"Kate Haviland"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:document:927e406b211f29d8d30e9f50a6e7c5996a5721bafe2dfd78b98fe89a08504954","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A bcax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:05:39.007738+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:12","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kiran-mazumdar-shaw-bcax","object_label":"Kiran Mazumdar-Shaw","object_source_name_forms":[],"value":"Kiran Mazumdar-Shaw: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kiran-mazumdar-shaw-bcax","name":"Kiran Mazumdar-Shaw"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:document:927e406b211f29d8d30e9f50a6e7c5996a5721bafe2dfd78b98fe89a08504954","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A bcax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:05:39.007738+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:13","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-powell-bcax","object_label":"Michael Powell","object_source_name_forms":[],"value":"Michael Powell: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-powell-bcax","name":"Michael Powell"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:document:927e406b211f29d8d30e9f50a6e7c5996a5721bafe2dfd78b98fe89a08504954","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A bcax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:05:39.007738+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:14","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ryan-cohlhepp-bcax","object_label":"Ryan Cohlhepp","object_source_name_forms":[],"value":"Ryan Cohlhepp: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ryan-cohlhepp-bcax","name":"Ryan Cohlhepp"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:document:927e406b211f29d8d30e9f50a6e7c5996a5721bafe2dfd78b98fe89a08504954","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A bcax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:05:39.007738+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:leadership_role:15","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:scott-robertson-bcax","object_label":"Scott Robertson","object_source_name_forms":[],"value":"Scott Robertson: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:scott-robertson-bcax","name":"Scott Robertson"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:document:927e406b211f29d8d30e9f50a6e7c5996a5721bafe2dfd78b98fe89a08504954","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A bcax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:05:39.007738+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_record:16","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC: Chair Scott Robertson; Members Scott Robertson (Chair); Carolyn Ng; Michael Powell","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","canonical_type":"audit","chair":"Scott Robertson","members":[{"display_name":"Scott Robertson","person_slug":"scott-robertson-bcax","is_chair":true},{"display_name":"Carolyn Ng","person_slug":"carolyn-ng-bcax","is_chair":false},{"display_name":"Michael Powell","person_slug":"michael-powell-bcax","is_chair":false}],"source_id":"governance_people_committees"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:ba527dee1414de817618527ef612d097a7faa1a57dce68db723c2f2627666edb","identity_scope":"representation_reference","source_type":"sec_proxy","title":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","publisher":"governance_people_committees","url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:17","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:scott-robertson-bcax","object_label":"Scott Robertson","object_source_name_forms":[],"value":"Scott Robertson: chair, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:scott-robertson-bcax","name":"Scott Robertson"},"source_id":"governance_people_committees"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:ba527dee1414de817618527ef612d097a7faa1a57dce68db723c2f2627666edb","identity_scope":"representation_reference","source_type":"sec_proxy","title":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","publisher":"governance_people_committees","url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:18","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:carolyn-ng-bcax","object_label":"Carolyn Ng","object_source_name_forms":[],"value":"Carolyn Ng: member, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","category":"audit","role":"member","person":{"alpha_id":"alpha:person:carolyn-ng-bcax","name":"Carolyn Ng"},"source_id":"governance_people_committees"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:ba527dee1414de817618527ef612d097a7faa1a57dce68db723c2f2627666edb","identity_scope":"representation_reference","source_type":"sec_proxy","title":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","publisher":"governance_people_committees","url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:19","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:michael-powell-bcax","object_label":"Michael Powell","object_source_name_forms":[],"value":"Michael Powell: member, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","category":"audit","role":"member","person":{"alpha_id":"alpha:person:michael-powell-bcax","name":"Michael Powell"},"source_id":"governance_people_committees"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:ba527dee1414de817618527ef612d097a7faa1a57dce68db723c2f2627666edb","identity_scope":"representation_reference","source_type":"sec_proxy","title":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","publisher":"governance_people_committees","url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:security_listing:20","subject_id":"alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"BCAX (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"BCAX","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:46:03.478019+00:00","sources":[{"id":"alpha:projection-evidence:f103d8d9f0172e65195a9e08016a429299a77ae35ed262aad96bdb36a602fbc8","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bicara-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-24T04:46:03.478019+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:f103d8d9f0172e65195a9e08016a429299a77ae35ed262aad96bdb36a602fbc8","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bicara-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-24T04:46:03.478019+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:927e406b211f29d8d30e9f50a6e7c5996a5721bafe2dfd78b98fe89a08504954","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A bcax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T00:05:39.007738+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:ba527dee1414de817618527ef612d097a7faa1a57dce68db723c2f2627666edb","identity_scope":"representation_reference","source_type":"sec_proxy","title":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC","publisher":"governance_people_committees","url":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026027320/bcax-20260427.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.832,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.795,"cross_source_agreement":0.75,"temporal_completeness":0.75},"diagnostics":{"published_claims":19,"factual_claims":19,"claims_with_linked_evidence":19,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":12,"temporal_claims_with_valid_from":9,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-24T04:46:03.478019+00:00","observed_at":"2026-10-24T04:46:03.478019+00:00","reviewed_at":"2026-10-24T04:46:03.478019+00:00","verified_at":"2026-10-24T04:46:03.478019+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":19,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/bicara-therapeutics-inc/evidence","section":"evidence","href":"https://registry.alpha.ac/api/public/companies/bicara-therapeutics-inc?format=record&section=evidence","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}